Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Neurology
A Review of the Current Understanding and Treatment of Alzheimer's Disease
CARE-MS II Follow-up: Improvements with Alemtuzumab Maintained for 4 Years
ADVANCE Results: PEG-IFN-β-1a Decreases Disability in RRMS
Roles for Genetic Testing in Epilepsy
CARE-MS I Follow-up: Alemtuzumab Efficacy, Safety for MS Treatment Maintained for More than 4 Years
ADVANCE Trial: PEG-IFN-β-1a Every 2 Weeks Significantly Improved Outcomes over 2 Years in RRMS
Treatment with Alemtuzumab Leads to Durable Benefits in Patients with Multiple Sclerosis
New Study Reveals That TCD is Better Used to Detect PFO than TEE
Rapid Reperfusion Therapy in Acute Ischemic Stroke Reduces Complications and Improves Outcomes
Blood Pressure Variability after ICH Predicts Poor Outcomes
Pages
Previous
Next
1
2
3
4
5
6
7
8
9